Scalable Architecture for a Room Temperature Solid-State Quantum Information Processor

The realization of a scalable quantum information processor has emerged over the past decade as one of the central challenges at the interface of fundamental science and engineering. Much progress has been made towards this goal. Indeed, quantum operations have been demonstrated on several trapped ion qubits, and other solid-state systems are approaching similar levels of control. Extending these techniques to achieve fault-tolerant operations in larger systems with more qubits remains an extremely challenging goal, in part, due to the substantial technical complexity of current implementations. Here, we propose and analyze an architecture for a scalable, solid-state quantum information processor capable of operating at or near room temperature. The architecture is applicable to realistic conditions, which include disorder and relevant decoherence mechanisms, and includes a hierarchy of control at successive length scales. Our approach is based upon recent experimental advances involving Nitrogen-Vacancy color centers in diamond and will provide fundamental insights into the physics of non-equilibrium many-body quantum systems. Additionally, the proposed architecture may greatly alleviate the stringent constraints, currently limiting the realization of scalable quantum processors.Comment: 15 pages, 6 figure

18F-Deoxyfluorination of Phenols via Ru π-Complexes

The deficiency of robust and practical methods for 18F-radiofluorination is a bottleneck for positron emission tomography (PET) tracer development. Here, we report the first transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for PET imaging

¹⁸F‑Deoxyfluorination of Phenols via Ru π‑Complexes

The deficiency of robust and practical methods for ¹⁸F-radiofluorination is a bottleneck for positron emission tomography (PET) tracer development. Here, we report the first transition-metal-assisted ¹⁸F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for PET imaging

¹⁸F‑Deoxyfluorination of Phenols via Ru π‑Complexes

The deficiency of robust and practical methods for ¹⁸F-radiofluorination is a bottleneck for positron emission tomography (PET) tracer development. Here, we report the first transition-metal-assisted ¹⁸F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for PET imaging

¹⁸F‑Deoxyfluorination of Phenols via Ru π‑Complexes

The deficiency of robust and practical methods for ¹⁸F-radiofluorination is a bottleneck for positron emission tomography (PET) tracer development. Here, we report the first transition-metal-assisted ¹⁸F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for PET imaging

Translation of HDAC6 PET Imaging Using [F-18]EKZ-001-cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates

Histone deacetylase 6 (HDAC6) is a multifunctional cytoplasmic enzyme involved in diverse cellular processes such as intracellular transport and protein quality control. Inhibition of HDAC6 can alleviate defects in cell and rodent models of certain diseases, particularly neurodegenerative disorders, including Alzheimer's disease and amyotrophic lateral sclerosis. However, while HDAC6 represents a potentially powerful therapeutic target, development of effective brain-penetrant HDAC6 inhibitors remains challenging. Recently, [18F]EKZ-001 ([18F]Bavarostat), a brain-penetrant positron emission tomography (PET) radioligand with high affinity and selectivity toward HDAC6, was developed and evaluated preclinically for its ability to bind HDAC6. Herein, we describe the efficient and robust fully automated current Good Manufacturing Practices (cGMP) compliant production method. [18F]EKZ-001 quantification methods were validated in nonhuman primates (NHP) using full kinetic modeling, and [18F]EKZ-001 PET was applied to compare dose-occupancy relationships between two HDAC6 inhibitors, EKZ-317 and ACY-775. [18F]EKZ-001 is cGMP produced with an average decay-corrected radiochemical yield of 14% and an average molar activity of 204 GBq/μmol. We demonstrate that a two-tissue compartmental model and Logan graphical analysis are appropriate for [18F]EKZ-001 PET quantification in NHP brain. Blocking studies show that the novel compound EKZ-317 achieves higher target occupancy than ACY-775. This work supports the translation of [18F]EKZ-001 PET for first-in-human studies.status: publishe